GlassScriptPhysician profile
Peyman A Elison
NPI 1861563132
$2,149.08
in general payments reported to CMS, 2019-2025
25 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $52.43 · 2021: $188 · 2022: $461 · 2023: $372 · 2024: $244 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $304.57 | 2021-2023 | Nuzyra |
| Smith+Nephew, INC. | $231.35 | 2019 | |
| Integra Lifesciences Corporation | $224.00 | 2021-2024 | Tenoglide, Biodoptix, Biofix |
| Stryker Corporation | $182.41 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $178.16 | 2022-2025 | Intellis Adaptivestim |
| Vaporox, INC. | $167.00 | 2023 | Vht-200 Wound Treatment System |
| Biowound Solutions, INC. | $123.91 | 2024-2025 | Bio-Connekt |
| Orthofix Medical, INC. | $122.43 | 2019-2024 | Physio-Stim, Spinal-Stim |
| Osiris Therapeutics INC. | $115.44 | 2019 | |
| Medtronic Vascular, INC. | $115.15 | 2019-2020 | |
| Djo, LLC | $67.36 | 2019-2023 | Cmf |
| Dynasplint Systems INC. | $52.56 | 2021 | |
| Kci USA, INC. | $40.42 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $28.65 | 2022 | |
| Bioventus LLC | $25.14 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $24.44 | 2025 | Miro3d |
| Wright Medical Technology, INC. | $22.22 | 2019 | |
| Abbott Laboratories | $20.56 | 2025 | Proclaim |
| Aap Implants INC | $17.77 | 2022 | |
| Horizon Therapeutics Plc | $17.18 | 2022 | |
| Abbvie INC. | $16.73 | 2021 | |
| Organogenesis INC. | $15.13 | 2019 | |
| Depuy Synthes Sales INC. | $13.12 | 2021 | |
| Melinta Therapeutics, LLC | $11.75 | 2019 | |
| Merck Sharp & Dohme LLC | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peyman Elison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.